[go: up one dir, main page]

FI871039A0 - Foerfarande foer bestaemmande av endoglykosidasaktivitet. - Google Patents

Foerfarande foer bestaemmande av endoglykosidasaktivitet.

Info

Publication number
FI871039A0
FI871039A0 FI871039A FI871039A FI871039A0 FI 871039 A0 FI871039 A0 FI 871039A0 FI 871039 A FI871039 A FI 871039A FI 871039 A FI871039 A FI 871039A FI 871039 A0 FI871039 A0 FI 871039A0
Authority
FI
Finland
Prior art keywords
endoglykosidasaktivitet
bestaemmande
foerfarande foer
foerfarande
foer
Prior art date
Application number
FI871039A
Other languages
English (en)
Other versions
FI871039A7 (fi
Inventor
Garth L Nicolson
Motowo Nakajima
Tatsuro Irimura
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Priority to FI924243A priority Critical patent/FI924243L/fi
Priority to FI924244A priority patent/FI924244A0/fi
Publication of FI871039A0 publication Critical patent/FI871039A0/fi
Publication of FI871039A7 publication Critical patent/FI871039A7/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01031Beta-glucuronidase (3.2.1.31)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G01N33/5751
    • G01N33/5756
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/924Hydrolases (3) acting on glycosyl compounds (3.2)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FI871039A 1986-03-10 1987-03-10 Foerfarande foer bestaemmande av endoglykosidasaktivitet. FI871039A7 (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI924243A FI924243L (fi) 1986-03-10 1987-03-10 Foerfarande foer bestaemmande av endoglykosidasaktivitet
FI924244A FI924244A0 (fi) 1986-03-10 1987-03-10 Foerfarande foer bestaemmande av endoglykosidasaktivitet.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83989086A 1986-03-10 1986-03-10
US07/012,860 US4859581A (en) 1986-03-10 1987-02-20 Endoglycosidase assay

Publications (2)

Publication Number Publication Date
FI871039A0 true FI871039A0 (fi) 1987-03-10
FI871039A7 FI871039A7 (fi) 1987-09-11

Family

ID=26684096

Family Applications (1)

Application Number Title Priority Date Filing Date
FI871039A FI871039A7 (fi) 1986-03-10 1987-03-10 Foerfarande foer bestaemmande av endoglykosidasaktivitet.

Country Status (6)

Country Link
US (2) US4859581A (fi)
EP (1) EP0244932A3 (fi)
AU (1) AU609386B2 (fi)
DK (1) DK122087A (fi)
FI (1) FI871039A7 (fi)
NO (1) NO870977L (fi)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883751A (en) * 1986-05-28 1989-11-28 New York University Specific immunoassay for heparin
CA1339812C (en) * 1988-02-19 1998-04-14 Tamami Koyama Filler for measuring enzyme activity, column packed with the filler, andmethod of measuring enzyme activity by using the column
GB8815975D0 (en) * 1988-07-05 1988-08-10 Procter & Gamble Method for evaluating detergent cellulases
DE69032406T2 (de) * 1989-08-23 1998-10-29 Zvi Fuks Wundheilmittel enthaltend heparanase
CA2083052A1 (en) * 1990-05-31 1991-12-01 Garth L. Nicolson Immunochemical localization of heparanase in mouse and human melanomas
ES2116331T3 (es) * 1991-01-15 1998-07-16 Biotie Therapies Oy Deteccion del contenido en sindecan en los materiales biologicos tales como tejidos o fluidos fisiologicos que indican transformaciones celulares malignas.
WO1992019768A1 (en) * 1991-05-07 1992-11-12 Oxford Glycosystems Limited Sequencing of oligosaccharides
JP3199405B2 (ja) * 1991-08-30 2001-08-20 生化学工業株式会社 肝細胞球状集塊化剤及び球状集塊化肝細胞の製造方法
DE4217474A1 (de) * 1992-05-27 1993-12-02 Boehringer Mannheim Gmbh Verfahren und Mittel zur Bestimmung eines Analyts
AU721069B2 (en) * 1993-04-14 2000-06-22 Litmus Concepts, Inc. Reporter enzyme release technology: methods of assaying for the presence of aspartic proteases and other hydrolytic enzyme activities
CZ289902B6 (cs) * 1993-04-14 2002-04-17 Litmus Concepts, Inc. Způsob zjią»ování přítomnosti enzymaticky aktivní hydrolázy ve vzorku a testovací zařízení pro provádění tohoto způsobu
US5416003A (en) * 1993-04-14 1995-05-16 Litmus Concepts, Inc. Reporter enzyme release technology: methods of assaying for the presence of aspartic proteases and other hydrolytic enzyme activities
AU7205894A (en) * 1993-06-08 1995-01-03 Neogenix, Inc. Purified natural and synthetic compounds for the treatment of osteoarthritis
US5753445A (en) * 1994-04-26 1998-05-19 The Mount Sinai Medical Center Of The City University Of New York Test for the detection of anti-heparin antibodies
US6228998B1 (en) * 1994-07-22 2001-05-08 Seikagaku Kogyo Kabushiki Kaisha Amino spacered glycosaminoglycan derivatives and their use in copolymerization with acrylamide
EP0848613A1 (en) * 1995-09-05 1998-06-24 Cambridge Neuroscience, Inc. Analogs for specific oligosaccharide-neuregulin interactions and uses thereof
DE19547684A1 (de) 1995-12-20 1997-06-26 Philips Patentverwaltung Verfahren und Anordnung zum kontaktlosen Übertragen
IL127043A0 (en) * 1996-05-14 1999-09-22 Univ Manitoba Solid-phase activity assay for biologically active substance
AUPN991796A0 (en) * 1996-05-17 1996-06-13 Women's And Children's Hospital Early detection of lysosomal storage disorders
TW565614B (en) * 1996-07-18 2003-12-11 Univ Australian Detection of mammalian heparanase activity and purification of mammalian heparanase
US20020088019A1 (en) * 1997-09-02 2002-07-04 Oron Yacoby-Zeevi Methods of and pharmaceutical compositions for improving implantation of embryos
US20040213789A1 (en) * 1997-09-02 2004-10-28 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US20030161823A1 (en) * 1998-08-31 2003-08-28 Neta Ilan Therapeutic and cosmetic uses of heparanases
US6699672B1 (en) 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
US6562950B2 (en) * 1997-09-02 2003-05-13 Insight Strategy & Marketing Ltd. Heparanase activity neutralizing anti-heparanase monoclonal antibody
US6190875B1 (en) * 1997-09-02 2001-02-20 Insight Strategy & Marketing Ltd. Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe
US20030217375A1 (en) * 1998-08-31 2003-11-20 Eyal Zcharia Transgenic animals expressing heparanase and uses thereof
EP1157118A4 (en) * 1999-03-01 2002-07-17 Insight Strategy & Marketing POLYNUCLEOTID ENCODING A POLYPEPTIDE WITH HEPARANASE ACTIVITY AND ITS EXPRESSION IN GENETICALLY MODIFIED CELLS
GB9913415D0 (en) * 1999-06-10 1999-08-11 Central Manchester Healthcare Heparanase assay
CA2286414A1 (en) * 1999-10-04 2001-04-04 Zhibo Gan Non-separation heterogenous assay for biological substance
PL366012A1 (pl) 2000-09-15 2005-01-24 Reddy Us Therapeutics, Inc. Kompozycja i sposób oznaczania glikozydazy
WO2002090574A1 (en) * 2001-05-09 2002-11-14 Insight Biopharmaceuticals Ltd. Methods and kits utilizing heparanase as a diagnostic marker for haemostatic disorders
US6671189B2 (en) * 2001-11-09 2003-12-30 Minebea Co., Ltd. Power converter having primary and secondary side switches
CH696701A5 (de) * 2001-12-18 2007-10-15 Hoffmann La Roche Verfahren zum Testen eines Mittels auf dessen Fähigkeit, die Heparanaseaktivität zu hemmen.
DE10258770B4 (de) * 2001-12-18 2005-02-10 F. Hoffmann-La Roche Ag Verfahren zum Testen eines Mittels auf dessen Fähigkeit, die Heparanaseaktivität zu hemmen
US7632654B2 (en) * 2002-04-29 2009-12-15 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Means and methods for detecting endoglycosidase activity
FR2843126B1 (fr) * 2002-08-01 2006-01-27 Cis Bio Int "methode de determination d'une activite enzymatique endoglycosidase"
WO2004108065A2 (en) * 2003-06-09 2004-12-16 Insight Biopharmaceuticals Ltd. Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies
WO2005040163A1 (en) * 2003-10-28 2005-05-06 Dr. Reddy's Laboratories Ltd Heterocyclic compounds that block the effects of advanced glycation end products (age)
US7521226B2 (en) 2004-06-30 2009-04-21 Kimberly-Clark Worldwide, Inc. One-step enzymatic and amine detection technique
US7094528B2 (en) 2004-06-30 2006-08-22 Kimberly-Clark Worldwide, Inc. Magnetic enzyme detection techniques
US7906276B2 (en) * 2004-06-30 2011-03-15 Kimberly-Clark Worldwide, Inc. Enzymatic detection techniques
US7504235B2 (en) * 2005-08-31 2009-03-17 Kimberly-Clark Worldwide, Inc. Enzyme detection technique
US8758989B2 (en) * 2006-04-06 2014-06-24 Kimberly-Clark Worldwide, Inc. Enzymatic detection techniques
US7897360B2 (en) 2006-12-15 2011-03-01 Kimberly-Clark Worldwide, Inc. Enzyme detection techniques
US7977102B2 (en) * 2007-06-15 2011-07-12 Los Alamos National Security, Llc Isotopically labeled compositions and method
EP2333555A1 (de) 2009-12-09 2011-06-15 Siemens Healthcare Diagnostics Products GmbH Heterogener Gerinnungstest
GB201305986D0 (en) * 2013-04-03 2013-05-15 Asociaci N Ct De Investigaci N Cooperativa En Biomateriales Synthesis and use of isotopically-labelled glycans
ES2564426B2 (es) * 2014-09-19 2016-09-12 Universidad De Oviedo Marcador de patologías oculares
BR112018013504B1 (pt) 2015-12-29 2022-08-09 Galderma S.A. Método para desacetilação pelo menos parcial de glicosaminoglicano compreendendo grupos acetila, glicosaminoglicano pelo menos parcialmente desacetilado, uso de hidroxilamina para desacetilação pelo menos parcial de glicosaminoglicano e método para preparar produto de hidrogel
EP3252080A1 (en) * 2016-05-31 2017-12-06 Galderma S.A. Method for preparing acylated crosslinked glycosaminoglycans
EP3252082A1 (en) * 2016-05-31 2017-12-06 Galderma S.A. Method for deacetylation of biopolymers
PT3623390T (pt) 2016-05-31 2023-10-27 Galderma Sa Reticulador de hidrato de carbono
WO2018067449A1 (en) * 2016-10-05 2018-04-12 Bio-Techne Corporation Methods and kits for assaying endoglycosidase activity
KR20220110786A (ko) 2019-12-02 2022-08-09 갈더마 홀딩 소시에떼 아노님 고분자량 에스테틱 조성물
CA3165060C (en) 2020-01-21 2023-06-20 Yiming Zhao Deglycosylation methods for electrophoresis of glycosylated proteins

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE336915B (fi) * 1968-01-15 1971-07-19 Pharmacia Ab
JPS6040859B2 (ja) * 1977-07-27 1985-09-12 喜温 三浦 抗血栓性人工医療材料
US4302536A (en) * 1978-08-15 1981-11-24 Longenecker Robert W Colorimetric immunoassay process
US4239664A (en) * 1978-10-31 1980-12-16 Research Corporation Anti-thrombogenic PVP-heparin polymer
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US4385046A (en) * 1980-12-15 1983-05-24 Minnesota Mining And Manufacturing Company Diagnostic radio-labeled polysaccharide derivatives
EP0098814B1 (en) * 1982-06-10 1986-10-15 KabiVitrum AB Antithrombin-heparin complex
US4677058A (en) * 1983-05-19 1987-06-30 Karl Tryggvason Detecting malignant cells with monoclonal antibodies specific to type IV collagenase enzyme
DE3519011A1 (de) * 1985-05-25 1986-11-27 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines materials zur affinitaetschromatographie

Also Published As

Publication number Publication date
DK122087A (da) 1987-12-04
US5332812A (en) 1994-07-26
AU6987087A (en) 1987-09-17
US4859581A (en) 1989-08-22
NO870977L (no) 1987-09-11
FI871039A7 (fi) 1987-09-11
DK122087D0 (da) 1987-03-10
AU609386B2 (en) 1991-05-02
NO870977D0 (no) 1987-03-10
EP0244932A3 (en) 1991-05-22
EP0244932A2 (en) 1987-11-11

Similar Documents

Publication Publication Date Title
FI871151L (fi) Anordning foer extrahering av en portionsinsats.
FI870789L (fi) Anordning foer anvaendning av laekemedelssuspensioner.
FI871039A0 (fi) Foerfarande foer bestaemmande av endoglykosidasaktivitet.
FI870250L (fi) Foerfarande foer torrkatjonisering av staerkelse.
FI870523L (fi) Braennare foer framstaellning av en foerform av optiska fibrer.
FI871313L (fi) Foerfarande foer framstaellning av laekemedelsadsorbat.
FI870995A7 (fi) Anordning foer foerbaettring av signaltransienter.
FI870249L (fi) Foerfarande foer torrkationisering av galaktomannaner.
FI82029B (fi) Anordning foer vaermehaerdning av glasskivor.
FI864549A0 (fi) Foerfarande foer koncentrering av uppslamningar.
FI871252L (fi) Foerfarande foer framstaellning av en elektroluminiscerande tunnfilmsstruktur.
FI864797A0 (fi) Foerfarande foer framstaellning av en alkoholdryck.
FI870459L (fi) Anordning foer detektering av mikro-organismer.
FI860660L (fi) Foerfarande foer reglering av gasstroemmars blandning.
FI870132L (fi) Extruderingsverktyg foer framstaellning av en flerskiktig slangfolie.
FI870446A0 (fi) Foerfarande foer framstaellning av karboxylsyraamider.
FI871214L (fi) Foerfarande foer framstaellning av perlitiska gjutjaernssorter.
FI870674A0 (fi) Framstaellning av cyanidhydratas.
FI862810A0 (fi) Foerfarande foer behandling av en pappersfabriks cirkulationsvatten.
FI860984A0 (fi) Koppling foer skyddning av mekanism.
FI863478A0 (fi) Av hopkopplade baerroer bestaoende belysningsarrangemang.
FI861809A0 (fi) Foerfarande foer framstaellning av en betongstenbelaeggning.
FI862415L (fi) Givare foer maetning av fibermassas stroemmningshastighet.
FI863519A0 (fi) Anordning foer uppsamling av paelsdjursspillning.
FI863772A0 (fi) Foerfarande foer luftkonditionering av rumsutrymmen.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: BOARD OF REGENTS